Operating results of "Lietuvos energijos gamyba", AB Group

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Operating results of "Lietuvos energijos gamyba", AB Group for the three-month period of 2014

Elektrėnai, Lithuania, 2014-05-30 08:00 CEST (GLOBE NEWSWIRE) -- Lietuvos Energijos Gamyba group‘s operating results improved due to increased electricity sales in the free market

The group of companies of Lithuania‘s largest electricity producer Lietuvos Energijos Gamyba (‘the Group’) has recorded LTL 59.5 million earnings before interest, tax, depreciation and amortisation (EBITDA). Successful trading in electricity in the free market and increased generation at hydro electric power plants have contributed to the good results of the Group.

The first three months of 2014 did not bring any surprises to the electricity market. January, February and March were slightly warmer than usual, with the average temperature in Lithuania exceeding the standard value, and there were no significant restrictions on intersystem capacities in this period, therefore, subsidised electricity was generated in Lithuania only by co-generation plants of the cities. In the January – March period, the average electricity price in the Lithuanian bidding area of Nord Pool Spot was 4.3% lower than in the same period of 2013 and was 146.5 Lt/MWh. For comparison, in September and October 2013, when import opportunities were significantly restricted, the average electricity price in the Lithuanian bidding area was almost 50% higher.

Thus, based on a stable situation in the electric power system and seeking to save the funds of the public interest services (PIS), the company was able to comply with the plan agreed with Litgrid, the Lithuanian transmission system operator, and not to put into operation the reserve generation units and the combined-cycle unit of the Elektrėnai complex during the January – March period of 2014. Furthermore, since the beginning of 2014 LESTO, the distribution network operator, started purchasing electricity on the exchange, which has led to a decrease of the Group’s sales under bilateral contracts.  As a result, the Group‘s revenues were reduced by one fourth: from LTL 221.9 million in the January-March period of 2013 to LTL 165.3 million in the same period of 2014.

According to Juozas Bartlingas, Chairman of the Board and CEO of Lietuvos Energijos Gamyba, the decrease in revenues has been compensated by the professionalism of the company‘s sales personnel, which has enabled the company increase the electricity sales in the free market by nearly one third, and by the increased power generation at the competitive Kaunas Hydroelectric Power Plant (‘Kaunas HPP’) and Kruonis Pumped Storage Hydroelectric Plant (‘Kruonis PSHP’) due to warm winter. ‘In addition, costs were reduced considerably in the first quarter of 2014 compared with the first quarter of 2013 due to lower expenses for fuel and the use of the opportunities for purchasing cheaper electricity. This has resulted in better profitability ratios of the Group in the first quarter of 2014 compared with last year’, says J. Bartlingas.

In the period of January – March 2014, the Group‘s EBITDA margin was 36%. Compared with the same period of 2013, the EBITDA margin has increased by 9.5 pp (from 26.5%). EBITDA has increased from LTL 58.8 million to LTL 59.5 million. The net profitability of the Group has grown by 16.8 pp: the net profitability ratio for the 3 months of 2014 was 3.1%, for the same period of this year 20%. Net profit of the Group in the period of January-March 2014 is LTL 33 million, which is nearly five times more than in the same period of 2013 (LTL 7 million).

‘We are pleased that successful operations of Lietuvos Energijos Gamyba are being noticed. As shown by the results of the procurement procedure for the refinancing of the company‘s loans, which was completed in the first quarter of this year, creditors’ trust in the company and the energy sector as a whole is growing, which enables us to realise our goals. We will continue focussing on our priorities: increase in the efficiency of operations, project development and analysis of new opportunities. We plan to put the new Elektrėnai thermal energy generation capacities into operation at the end of 2014, and are continuing wind measurements in the territory of Kruonis PSHP. The results of these measurements will form a basis for our decision on the feasibility of construction of a wind farm next year‘, says J. Bartlingas.

Production indicators

The electricity generation volume of all the company‘s power plants totalled 0.245 TWh in the 3 months of 2014. Last year it amounted to 0.3 TWh, which is 22.4% more.  

As already mentioned above, no electricity was generated at the Elektrėnai complex during the first 3 months of this year. It had been planned last year that in the period from 1 April until 15 October the operation of the units of the complex would be based on a schedule agreed with Litgrid, in order to ensure a reliable operation of the power system and an efficient use of the PIS funds allotted to the Elektrėnai power plant.

During the 3 months of 2014, Kaunas HPP generated 0.113 TWh of electricity, which is 12% more than in the same period of 2013. The average flow rate in the River Nemunas was higher in January and February, and close to the average multi-annual flowrate in March. 

Production volumes of Kruonis PSHP increased 8% during the 3 months of this year compared with the same period of last year: the power plant produced 0.132 TWh of electricity.

Regulated and commercial activities

In the first quarter of 2014, there has been a decrease in the Group‘s revenues from both regulated and commercial activities, however, the share of the latter in the overall revenue structure has been increasing: commercial revenues accounted for 59% of total revenues in the 3 months of 2013 and for nearly 65% in the same period of 2014.

Regulated activities of the Group include the generation of electric and heat energy at the Elektrėnai complex and the power reserving services provided by Kruonis PSHP and the Elektrėnai complex. As no electricity was generated at Elektrėnai, the Group‘s revenue earned from regulated activities during the 3 months of 2014 was 36% lower compared with the same period of 2013 (LTL 58.3 million).

Revenues from commercial activities, which consist of the electricity generation at Kruonis PSHP and Kaunas HPP and the wholesale and retail trading in electricity in the free market as well as other commercial services, have dropped 18%. Due to the change in the arrangement of electricity sale to LESTO, revenues from commercial activities decreased from LTL 131 million during the 3 months of 2013 to LTL 107 million in the same period of 2014.

The Group‘s electricity sales in the free market during the 3 months of 2014 increased 30% compared with the same period of 2013 (0.414 TWh and 0.318 respectively). Professional trading activities have enabled the Group to increase its EBITDA from LTL 20 million for the 3 months of 2013 to LTL 30 million for the 3 months of 2014.

The company has started trading according to the gross bidding arrangement in March 2014 and is concluding its electricity purchase and sale transactions separately. The company is determined to continue its contribution to enhancing market transparency and, at the same time, it will seek to maximise the use of the opportunities provided by Kaunas HPP and Kruonis PSHP to compete in the market by the electricity price.

Lietuvos Energijos Gamyba, AB is a company listed on NASDAQ OMX Vilnius Electricity Exchange. 96.13% of its shares are held by Lietuvos Energija, UAB, a state-controlled private company.

The Group of Lietuvos Energijos Gamyba consists of the parent company Lietuvos Energijos Gamyba, AB, which controls the reserve power plant and the combined-cycle unit in Elektrėnai, the Kruonis Pumped Storage Hydroelectric Plant and the Kaunas Hydroelectric Power Plant, as well as of private companies Energijos Tiekimas UAB and Kauno Energetikos Remontas UAB.

         Valentas Neviera          Head of Corporate Communication Division          Lietuvos Energijos Gamyba, AB          Tel. +370 619 62019          Email: valentas.neviera@le.lt

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 219

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 272

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 235

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 319

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 365

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 468

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 314

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Affordable Technology Solutions with Human-I-T's Initiative

Updated Category News Views 184

Human-I-T Launches 'Get It Done' Initiative to Bridge Digital Divide Human-I-T has unveiled its new 'Get It Done' Initiative aimed at making essential technology accessible to everyone without straining their finances. This program focuses on providing quality refurbished laptops at an affordable price, ensuring that individuals and families can benefit from reliable...

Continue Reading
Jasper Street Launches Activism Defense Practice with New Partners

Updated Category News Views 125

Jasper Street Partners Strengthens Activism Defense Practice Jasper Street Partners is gearing up to enhance its defense against activist investors by bringing on board two experienced bankers. Their main objective is clear: to assist clients in identifying weaknesses, navigating proxy contests, and managing the pressures that come with public activism. Introducing New...

Continue Reading
Royalty Pharma's $300 Million Partnership with Zenas BioPharma

Updated Category News Views 139

Funding Agreement for Obexelimab Development Royalty Pharma plc and Zenas BioPharma, Inc. have joined forces in a groundbreaking funding agreement that could inject up to $300 million into the development of obexelimab, a promising treatment for autoimmune diseases, specifically IgG4-Related Disease (IgG4-RD). This alliance highlights Royalty Pharma’s commitment to...

Continue Reading
KBR, Inc. Shares Drop Significantly Following Contract News

Updated Category News Views 242

Significant Decline in KBR, Inc. Shares KBR, Inc. (NYSE: KBR) recently faced a substantial decline in its stock value. This shift came after the announcement regarding the termination of a key contract, leaving many investors anxious about the company's future prospects. The market reacted sharply, indicating the level of uncertainty surrounding KBR's operations and...

Continue Reading
Dr. Mike Varshavski to Address Medical Misinformation Soon

Updated Category News Views 407

Dr. Mike Varshavski to Discuss Medical Misinformation The National Press Club is set to host a compelling event featuring Dr. Mikhail "Dr. Mike" Varshavski, a well-known physician and a social media phenomenon. This exciting Headliners event will take place soon, and attendees can expect an engaging dialogue focused on vital issues surrounding medical misinformation and...

Continue Reading